“…Although a matter of controversy for many years, it now seems clear that ECM components are involved in development of the CNS as well (Sanes, 1989;Reichardt and Tomaselli, 199 1). Glycosaminoglycans, defined by labeling with cationic dyes, are present in the cerebral cortex of the mouse (Derer and Nakanishi, 1983;Nakanishi, 1983;Bruckner et al, 1985) and in the chick's optic tectum just ahead of arriving optic nerve axons (Krayanek, 1980). Immunolabeling with antibodies against fibronectin (IN;Hatten et al, 1982;Stewart and Pearlman, 1987;Chun and Shatz, 1988;Stallcup et al, 1989) proteoglycans (Aquino et al, 1984;Margolis and Margolis, 1989;Snow et al, 1990b), hyaluronectin (Delpech and Delpech, 1984;Bignami and Delpech, 1985), laminin (Liesi, 1985;Letoumeau et al, 1988;Liesi and Silver, 1988;McLoon et al, 1988;Hagg et al, 1989), tenascin (Crossin et al, 1989;Steindler et al, 1989), and thrombospondin (O'Shea et al, 1990) has been demonstrated in the developing CNS of the rodent, and extracellular material that has not been characterized with antibody markers is evident with electron microscopy in the cortical subplate and marginal zones (Derer and Nakanishi, 1983;Nakanishi, 1983;Hankin and Silver, 1988).…”